Home
Our Experts
Become an Expert
Ask A Question
PharmaLive
Pharmalot
Ask A Question
The * denotes a required field.
Ask A Question
Your Name
*
Email
*
Job Title
Topic
Accelerated Proof-of-Concept
Drug Delivery Technologies
Imaging
Subject
Question
*
Archives
Select Month
April 2010 (4)
March 2010 (2)
February 2010 (2)
January 2010 (6)
October 2009 (4)
September 2009 (2)
August 2009 (2)
July 2009 (4)
April 2009 (2)
Our Experts
David M. Oakley, R.Ph., Ph.D.
Graham Wood, PhD
Richard Walovitch, Ph.D.
Our Current Topics
Accelerated Proof-of-Concept
Drug Delivery Technologies
Imaging
Recent Questions
With evidence showing that women are at a higher risk than men for proarrhythmias linked with QTc prolongation, should the issue of gender receive more consideration when enrolling through QT studies?...
A student asks, “How feasible is the nasal route to deliver peptides into the brain to treat Alzheimer’s disease?”...
Have tangible strides been made in using PET scanning to study brain receptor occupancy? Has the tool helped make dosage decisions easier in trials for Alzheimer’s and other CNS drugs?...
With so many disciplines involved, what unique training and background should be required for clinical molecular imagers?...
In your opinion, how early should the container closer system be considered or introduced in a clinical trial?...
What particular challenges do companies face when attempting to formulate DNA vaccines?...
What advantages do microemulsion formulations offer specifically for topical and transdermal drug delivery?...
